Lenvatinib
Product Specifications
CAS Number
417716-92-8
Target
C-RET|||VEGFR|||FGFR|||PDGFR|||c-Kit
Related Pathways
Tyrosine Kinase/Adaptors|||Apoptosis|||Angiogenesis
Purity
0.9996
Bioactivity
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity. Lenvatinib has the strongest inhibitory activity on VEGFR2 and VEGFR3 (IC50=4/5.2 nM) . Lenvatinib has strong anti-tumor activity.
Smiles
O(C=1C2=C(C=C(OC)C(C(N)=O)=C2)N=CC1)C3=CC(Cl)=C(NC(NC4CC4)=O)C=C3
Molecular Formula
C21H19ClN4O4
Molecular Weight
426.85
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
123383-APC 100 µL
AP4B1 (AP-4 Complex Subunit beta-1, AP-4 Adapter Complex Subunit beta, Adapter-related Protein Complex 4 Subunit beta-1, Beta Subunit of AP-4, Beta4-adaptin) (APC)
Ask
View Details 
